Pfizer’s Covid-19 Shot Offers 100% Long-Term Protection For Young Teens, Trial Shows

Pfizer and BioNTech said the long-term data, measured from seven days to four months after the second dose, would form the basis of a submission for full regulatory approval.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive